CN114404517A - Composition for gout and reducing uric acid and application and preparation method thereof - Google Patents
Composition for gout and reducing uric acid and application and preparation method thereof Download PDFInfo
- Publication number
- CN114404517A CN114404517A CN202210116349.6A CN202210116349A CN114404517A CN 114404517 A CN114404517 A CN 114404517A CN 202210116349 A CN202210116349 A CN 202210116349A CN 114404517 A CN114404517 A CN 114404517A
- Authority
- CN
- China
- Prior art keywords
- parts
- citrate
- composition
- raw materials
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 47
- 201000005569 Gout Diseases 0.000 title claims abstract description 42
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 title claims abstract description 32
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 title claims abstract description 31
- 229940116269 uric acid Drugs 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 53
- 239000002994 raw material Substances 0.000 claims abstract description 40
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 27
- 239000000463 material Substances 0.000 claims abstract description 26
- 239000004375 Dextrin Substances 0.000 claims abstract description 22
- 229920001353 Dextrin Polymers 0.000 claims abstract description 22
- 235000019425 dextrin Nutrition 0.000 claims abstract description 22
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 21
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 20
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 20
- 229940094952 green tea extract Drugs 0.000 claims abstract description 20
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 20
- OAVRWNUUOUXDFH-UHFFFAOYSA-H 2-hydroxypropane-1,2,3-tricarboxylate;manganese(2+) Chemical compound [Mn+2].[Mn+2].[Mn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O OAVRWNUUOUXDFH-UHFFFAOYSA-H 0.000 claims abstract description 19
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 19
- 229960002413 ferric citrate Drugs 0.000 claims abstract description 19
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 19
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims abstract description 19
- 235000011477 liquorice Nutrition 0.000 claims abstract description 19
- 239000011564 manganese citrate Substances 0.000 claims abstract description 19
- 229940097206 manganese citrate Drugs 0.000 claims abstract description 19
- 235000014872 manganese citrate Nutrition 0.000 claims abstract description 19
- 239000001508 potassium citrate Substances 0.000 claims abstract description 19
- 229960002635 potassium citrate Drugs 0.000 claims abstract description 19
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 claims abstract description 19
- 235000011082 potassium citrates Nutrition 0.000 claims abstract description 19
- 239000001509 sodium citrate Substances 0.000 claims abstract description 19
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000001035 drying Methods 0.000 claims abstract description 18
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 11
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 11
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 11
- 239000002674 ointment Substances 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 10
- 229960001790 sodium citrate Drugs 0.000 claims abstract description 10
- 235000011083 sodium citrates Nutrition 0.000 claims abstract description 10
- 238000000227 grinding Methods 0.000 claims abstract description 9
- 238000004140 cleaning Methods 0.000 claims abstract description 7
- 238000005303 weighing Methods 0.000 claims abstract description 7
- 238000012545 processing Methods 0.000 claims abstract description 6
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 5
- 244000182216 Mimusops elengi Species 0.000 claims abstract 3
- 238000000034 method Methods 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 14
- 241000169546 Lycium ruthenicum Species 0.000 claims description 11
- 244000241838 Lycium barbarum Species 0.000 claims description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 9
- 235000015468 Lycium chinense Nutrition 0.000 claims description 9
- 230000009467 reduction Effects 0.000 claims description 7
- 239000002775 capsule Substances 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000010298 pulverizing process Methods 0.000 claims description 6
- 238000007873 sieving Methods 0.000 claims description 5
- 241000037831 Polygonatum sibiricum Species 0.000 claims description 4
- 241000208340 Araliaceae Species 0.000 claims 4
- 241000723353 Chrysanthemum Species 0.000 claims 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 235000005911 diet Nutrition 0.000 abstract description 4
- 230000037213 diet Effects 0.000 abstract description 4
- 238000002560 therapeutic procedure Methods 0.000 abstract description 4
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000007774 longterm Effects 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 description 16
- 240000004371 Panax ginseng Species 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 235000013305 food Nutrition 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 10
- 240000002624 Mespilus germanica Species 0.000 description 8
- 244000269722 Thea sinensis Species 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000026435 phlegm Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 235000009569 green tea Nutrition 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000035922 thirst Effects 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 201000001431 Hyperuricemia Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 208000000044 Amnesia Diseases 0.000 description 2
- 208000031091 Amnestic disease Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 208000012886 Vertigo Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 230000006986 amnesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 231100000889 vertigo Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241000173699 Lonicera dasystyla Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 235000017848 Rubus fruticosus Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000021029 blackberry Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 229940106705 chlorophyll Drugs 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- -1 stomach invigorating Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
Abstract
The invention discloses a composition for gout and reducing uric acid, and application and a preparation method thereof, wherein the composition comprises the following components: ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum, cordyceps militaris, honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate. The invention also provides the application of the composition in preparing oral medicaments. The invention also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials, cleaning and drying the washable medicinal materials in the raw materials, grinding and crushing the medicinal materials, adding water for decoction, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding the rest raw materials, uniformly mixing, and finally processing into an oral medicament. The composition provided by the invention can be used in medicine-food homologous medicaments for various types of gout and related diseases, and can reduce uric acid without long-term adoption of diet therapy, so that patients can recover.
Description
Technical Field
The invention relates to a pharmaceutical composition, application and a preparation method thereof, in particular to a composition for treating gout and reducing uric acid, and application and a preparation method thereof.
Background
Gout (Gout) is a common and complex type of arthritis that can develop in all age groups, with men having a higher incidence than women. Patients with gout often have sudden joint pain at night, the joint is in urgent attack, severe pain, edema, red swelling and inflammation appear at the joint, and the pain is slowly relieved until the pain disappears for days or weeks. Gout attack is related to the concentration of uric acid in a body, and gout can form urate deposition in joint cavities and the like, activate the immune system of the body, and further cause acute joint pain.
There are two main methods of treating gout, namely a medication method and a diet therapy method. The medicines for treating gout mainly comprise non-steroidal anti-inflammatory drugs and glucocorticoids, but the current methods for treating gout by medicines are less in use; drinking with low food is a more common treatment. Dietotherapy mainly aims at reducing consumption of high-purine food, high-fat food and the like. The more purine content in human body, the more uric acid is produced by metabolism, and the alcohol stimulates liver to produce uric acid, which increases the incidence rate of gout and the harm of gout to human body.
However, products made of natural Chinese herbal medicines and other components are not adopted in domestic and world markets at present, and the processed and produced health-care and treatment medicament with homology of medicine and food for gout and other diseases can reduce uric acid without adopting diet therapy for a long time, so that patients can recover.
Disclosure of Invention
The invention aims to provide a pharmaceutical composition, and an application and a preparation method thereof, the pharmaceutical composition can be used for solving the existing problems, is used for gout and other diseases, and can reduce uric acid by using medicinal and edible raw materials and medicinal materials without adopting diet therapy for a long time, so that patients can recover.
In order to achieve the above objects, the present invention provides a composition for gout and uric acid reduction, wherein the composition comprises the following raw materials: ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum, cordyceps militaris, honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate.
The composition for treating gout and reducing uric acid is characterized in that polygonatum sibiricum is adopted as raw materials of the composition, and lycium ruthenicum is adopted as medlar.
The composition for treating gout and reducing uric acid comprises the following raw materials in parts by weight: 20-30 parts of ginseng, 20-30 parts of orange peel, 15-25 parts of resistant dextrin, 30-40 parts of honeysuckle extract, 20-30 parts of green tea extract, 30-40 parts of Jiuhua sealwort, 25-35 parts of sodium citrate, 30-40 parts of liquorice, 25-35 parts of potassium citrate, 45-55 parts of black wolfberry, 25-35 parts of ferric citrate, 25-35 parts of chrysanthemum, 25-35 parts of manganese citrate and 40-50 parts of cordyceps militaris.
The composition for treating gout and reducing uric acid comprises the following raw materials in parts by weight: 25g of ginseng, 25g of orange peel, 20g of resistant dextrin, 35g of honeysuckle extract, 25g of green tea extract, 35g of Jiuhua sealwort, 30g of sodium citrate, 35g of liquorice, 30g of potassium citrate, 50g of black wolfberry, 30g of ferric citrate, 30g of chrysanthemum, 30g of manganese citrate and 45g of cordyceps militaris.
The invention also provides application of the composition for treating gout and reducing uric acid, wherein the composition is used for preparing an oral medicament.
The invention also provides a preparation method of the medicament, wherein the method comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable medicinal materials in the raw materials, grinding and crushing the medicinal materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding the rest raw materials, uniformly mixing, and finally processing into an oral medicament.
The preparation method of the medicament comprises the steps of crushing and pulverizing ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum and cordyceps militaris, adding water for decoction, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate, adding other auxiliary materials according to requirements, mixing uniformly, grinding and sieving to obtain medicinal powder.
The preparation method of the medicament comprises the following steps of taking the medicinal powder as granules, and taking the granules with warm boiled water; or encapsulating to obtain capsule.
The composition for gout and reducing uric acid provided by the invention and the application and the preparation method thereof have the following advantages:
the invention utilizes the technologies of biological pharmacy and the like and high purification and extraction means, and the cooperation and verification of the Chinese medical science college of the Chinese academy of sciences break through the prior art of treating and recovering gout and related diseases, the obtained medicament can effectively aim at the diseases of gout and the like, takes the theory of the traditional Chinese medicine as guidance, preferably selects raw materials and medicinal materials with homology of medicine and food as basic collocation, combines the modern advanced biochemical pharmacy technology, improves the metabolism and the excretion capability of a body from the angles of calming the liver, warming the kidney and strengthening the spleen of the traditional Chinese medicine, further internalises the generation process of hyperuricemia, purifies blood, improves the capability of dissolving and crystallizing blood, and can effectively treat the gout and hyperuricemia after being taken.
Detailed Description
The following further describes embodiments of the present invention.
The invention provides a composition for gout and reducing uric acid, which comprises the following raw materials: the raw materials of the composition comprise: ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum, cordyceps militaris, honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate.
Wherein the Ginseng radix is a perennial herb, and contains multiple saponin and polysaccharide components. The succulent root of ginseng is a well-known tonic, is suitable for regulating blood pressure, recovering heart function, neurasthenia and asthenia, and also has expectorant, stomach invigorating, diuretic and exciting effects. Sweet and slightly bitter in taste, warm and mild in nature. It enters spleen, lung and heart meridians. Has effects of invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, tranquilizing, and improving intelligence. Mainly treats asthenia, desire for desertion, cold limbs and a little pulse, spleen deficiency, poor appetite, lung deficiency, cough and asthma, body fluid deficiency, thirst, internal heat, diabetes, deficiency of deficiency caused by chronic diseases, palpitation, insomnia, impotence and cold womb; heart failure, cardiogenic shock. Can be used for treating short breath, dyspnea, palpitation, amnesia, thirst, hyperhidrosis, anorexia, asthenia, acute and chronic diseases, and shock and collapse caused by blood loss. Tonify primordial qi, relieve depletion and promote fluid production, induce tranquilization. It is indicated for deficiency due to overstrain, poor appetite, lassitude, regurgitation, diarrhea, cough, dyspnea, spontaneous sweating, palpitation, amnesia, vertigo, headache, impotence, frequent micturition, diabetes, metrorrhagia, metrostaxis, chronic infantile convulsion, and deficiency of both qi and blood.
Pericarpium Citri Tangerinae. The pericarpium Citri Tangerinae is dried mature pericarp of Rutaceae plant fructus Citri Tangerinae and its cultivar; picking mature fruit, peeling peel, and drying in the sun or at low temperature. Bitter and pungent taste, warm in nature; entering lung and spleen meridians; has the effects of regulating qi, strengthening spleen, eliminating dampness and phlegm; it can be used for treating abdominal distention, anorexia, vomiting, diarrhea, cough, and excessive phlegm; it is combined with cang Zhu and Hou Po to treat gastric and abdominal distention and pain, nausea, vomiting and diarrhea due to cold-dampness in middle energizer and qi stagnation in spleen and stomach.
The rhizoma Polygonati is Jiuhua rhizoma Polygonati. Jiuhua Polygonatum sibiricum Red is a special product in Qingyang county of Anhui province, and is prepared by planting and digging Polygonatum sibiricum Red in the peripheral area of Jiuhua mountain. Jiuhua rhizoma polygonati, also called Dizang rhizoma polygonati, has the functions of food and medicine, has the functions of tonifying middle-jiao energy, strengthening muscles and bones and reducing high blood pressure, and can effectively enhance the immunologic function of a human body. The main functional components of the health-care food are polygonatum polysaccharide, amino acid, trace elements, anthraquinone and the like, and the health-care food is also rich in various trace elements necessary for human bodies, and various components such as protein, starch, amino acid, rehmannia root and the like, and has the effects of tonifying kidney, reducing blood, preventing arteriosclerosis, promoting insulin activity and the like.
The Glycyrrhrizae radix is dried root and rhizome of Glycyrrhiza uralensis Fisch, Glycyrrhiza inflata Bat or Glycyrrhiza glabra L of Leguminosae. Collected in spring and autumn, removed fibrous root, and dried in the sun. Sweet in flavor and neutral in nature. It enters heart, lung, spleen and stomach meridians. Has the effects of invigorating spleen and replenishing qi, clearing away heat and toxic materials, eliminating phlegm and stopping cough, relieving spasm and pain, and harmonizing the medicines. It is indicated for spleen and stomach deficiency, lassitude and hypodynamia, palpitation and shortness of breath, cough with profuse sputum, spasm and pain of abdomen and limbs, carbuncle and sore, and to relieve toxicity and strong action of drugs.
The fructus Lycii is fructus Lycii, i.e. the fruit of Lycium ruthenicum Murr. Lycium ruthenicum Murr of Solanaceae is Bush with spiny thorn, and has effects of blooming and fruiting in 5-10 months, purple black berry, spherical shape, kidney shape seed, and brown color. The lycium ruthenicum murr is sweet in taste and neutral in nature, and is rich in various nutritional ingredients such as protein, lycium ruthenicum polysaccharide, amino acid, vitamins, mineral substances, trace elements and the like. Besides the similar efficacy of the lycium ruthenicum murr, the lycium ruthenicum murr also contains rich lycium ruthenicum pigment (natural procyanidine, OPC for short), the OPC content of the lycium ruthenicum murr exceeds that of blueberry, and the lycium ruthenicum murr is a natural wild plant with the highest OPC content discovered up to now. Procyanidins OPC are the most effective natural water-soluble radical scavengers.
The flos Chrysanthemi is dry capitula of Chrysanthemum morifolium Ramat of Compositae. Pungent, sweet, bitter and slightly cold in nature; it enters lung and liver meridians. Has the effects of dispelling wind and heat, suppressing liver yang, removing liver heat, improving eyesight, and clearing away heat and toxic materials. It can be used for treating wind-heat type common cold, early stage of epidemic febrile disease, vertigo due to liver-yang, excessive liver-wind, conjunctival congestion, blurred vision, sore, carbuncle, and toxic swelling.
Cordyceps militaris is fungus of Cordyceps of Clavipitaceae, also called Cordyceps militaris, and abbreviated as Cordyceps militaris. Cordyceps militaris is a complex composed of a stroma (i.e., grass part) and a sclerotium (i.e., cadaver part of the insect). Cordyceps militaris is a fungus used as both food and medicine, the protein content of the fungus is as high as 40.7%, and the contained amino acids necessary for human body are complete in variety, sufficient in quantity and appropriate in proportion. The artificially cultivated cordyceps militaris also contains abundant vitamins, minerals and the like, and has good edible value. The cordyceps militaris stroma can be used as a medicine, has mild nature and sweet taste, benefits lung and kidney, stops bleeding and reduces phlegm, and can be generally used for treating pulmonary tuberculosis, weakness of old people, anemia and weakness and the like. Cordyceps militaris contains abundant cordycepic acid, cordycepin, ergosterol, etc., and has effects of expanding trachea, tranquilizing, resisting various bacteria, and lowering blood pressure.
The honeysuckle extract is an extract extracted from a natural plant honeysuckle, mainly contains chlorogenic acid, is brown powder in color, and can be used as a raw material of medicines, health-care products and cosmetics. The flos Lonicerae is dried bud or flower with initial blossom of Lonicera Japonica Thunb, Lonicera hypoglauca Miq, Lonicera confusa or Lonicera dasystyla of Caprifoliaceae. Sweet in nature and taste and cold in nature; it enters lung, heart and stomach meridians. Has the effects of clearing away heat and toxic materials, and dispelling pathogenic wind and heat. It is mainly used for treating carbuncle, furuncle, wind-heat type affection, early stage of epidemic febrile disease, and dysentery with blood due to toxic heat. The pharmacological actions include resisting pathogenic microorganism, resisting virus, resisting inflammation, promoting phagocytic function of inflammatory cell, reducing blood lipid, exciting central nerve, resisting fertility, and treating sarcoma S180 and Ehrlich ascites carcinoma with obvious cytotoxic effect.
The green tea extract is an active ingredient extracted from green tea leaves, and mainly comprises tea polyphenol (catechin), caffeine, aromatic oil, water, minerals, pigments, carbohydrates, proteins, amino acids, vitamins, etc. The green tea is prepared by fermenting, retains natural substances of fresh leaves, and contains more nutrients such as tea polyphenols, catechin, chlorophyll, caffeine, amino acids, vitamins, etc. The natural nutrient components in the green tea have special effects of anti-aging, cancer prevention, cancer resistance, sterilization, inflammation diminishing and the like, and are beyond the reach of other tea. Modern science has proved that the green tea contains biochemical components closely related to human health, and has pharmacological actions of refreshing, clearing away heat, relieving summer-heat, promoting digestion, reducing phlegm, removing greasiness, reducing weight, clearing away heart-fire, relieving restlessness, removing toxic substances, relieving hangover, promoting fluid production, quenching thirst, lowering fire, improving eyesight, relieving dysentery, eliminating dampness, etc., and has certain pharmacological effects on modern diseases, such as radiation disease, cardiovascular and cerebrovascular diseases, cancer, etc. The green tea is bitter and sweet in nature and cool. The main functional indications are as follows: clearing head and eyes, removing polydipsia, reducing phlegm, promoting digestion, promoting urination and removing toxicity. It is indicated for headache, blurred vision, insomnia, restlessness, thirst, food stagnation, phlegm stagnation, malaria and dysentery.
The resistant dextrin is processed by starch, is a low-calorie glucan which is prepared by extracting and refining indigestible components of baked dextrin by using industrial technology, and belongs to low-molecular water-soluble dietary fiber. The resistant dextrin has low calorie, heat resistance, acid resistance and freezing resistance, can be used as a low-calorie soluble food raw material, and has wide development prospect in the food industry.
Preferably, the composition comprises the following raw materials in parts by weight: 20-30 parts of ginseng, 20-30 parts of orange peel, 15-25 parts of resistant dextrin, 30-40 parts of honeysuckle extract, 20-30 parts of green tea extract, 30-40 parts of Jiuhua sealwort, 25-35 parts of sodium citrate, 30-40 parts of liquorice, 25-35 parts of potassium citrate, 45-55 parts of black wolfberry, 25-35 parts of ferric citrate, 25-35 parts of chrysanthemum, 25-35 parts of manganese citrate and 40-50 parts of cordyceps militaris.
More preferably, the raw materials of the composition comprise by weight: 25g of ginseng, 25g of orange peel, 20g of resistant dextrin, 35g of honeysuckle extract, 25g of green tea extract, 35g of Jiuhua sealwort, 30g of sodium citrate, 35g of liquorice, 30g of potassium citrate, 50g of black wolfberry, 30g of ferric citrate, 30g of chrysanthemum, 30g of manganese citrate and 45g of cordyceps militaris.
The raw materials are wild Chinese herbal medicines, and perennial Chinese herbal medicines are five years or more. The material is obtained from wild rare animals and plants, and can be artificially cultured and planted under the condition that conditions are not allowed, or other substitutes with equal and similar effects.
The invention also provides application of the composition for treating gout and reducing uric acid, and the composition is used for preparing an oral medicament.
The invention also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials in proportion, cleaning and drying the washable medicinal materials in the raw materials, grinding and crushing the medicinal materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding the rest raw materials, uniformly mixing, and finally processing into an oral medicament.
Preferably, in the method, ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum and cordyceps militaris are crushed and pulverized, water is added for decoction, liquid medicine is obtained after filtration, ointment is obtained after further concentration, honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate are added after drying, other auxiliary materials can be added according to the needs, the mixture is uniformly mixed, and finally the mixture is ground and sieved to obtain medicinal powder.
The obtained medicinal powder is taken as granule with warm boiled water; or encapsulating to obtain capsule, and administering with warm water.
In the method, preferably, the ointment obtained by concentration is added with auxiliary materials to be prepared into pills, or is prepared into tablets by tabletting.
The auxiliary materials adopted in the method are common auxiliary materials used in pharmaceutical technology and known by the technical personnel in the field.
Other specific conditions and equipment, etc. employed in the process are known to those skilled in the art.
The composition for gout and uric acid reduction provided by the invention, and the use and preparation method thereof are further described below with reference to examples.
Example 1
A composition for gout and reducing uric acid, which comprises the following raw materials in percentage by weight:
25g of ginseng, 25g of orange peel, 20g of resistant dextrin, 35g of honeysuckle extract, 25g of green tea extract, 35g of Jiuhua sealwort, 30g of sodium citrate, 35g of liquorice, 30g of potassium citrate, 50g of black wolfberry, 30g of ferric citrate, 30g of chrysanthemum, 30g of manganese citrate and 45g of cordyceps militaris.
The embodiment also provides application of the composition for treating gout and reducing uric acid, and the composition is used for preparing oral medicaments.
The embodiment also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials according to a certain proportion, cleaning and drying the washable medicinal materials in the raw materials, crushing and pulverizing ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum and cordyceps militaris, adding water for decoction, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate, adding other auxiliary materials according to requirements, uniformly mixing, and finally grinding and sieving to obtain medicinal powder.
The obtained medicinal powder can be used as granule to be taken with warm boiled water.
Example 2
A composition for gout and reducing uric acid, which comprises the following raw materials in percentage by weight:
20g of ginseng, 20g of orange peel, 15g of resistant dextrin, 30g of honeysuckle extract, 20g of green tea extract, 30g of Jiuhua sealwort, 25g of sodium citrate, 30g of liquorice, 25g of potassium citrate, 45g of black wolfberry, 25g of ferric citrate, 25g of chrysanthemum, 25g of manganese citrate and 40g of cordyceps militaris.
The embodiment also provides application of the composition for treating gout and reducing uric acid, and the composition is used for preparing oral medicaments.
The embodiment also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials according to a certain proportion, cleaning and drying the washable medicinal materials in the raw materials, crushing and pulverizing ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum and cordyceps militaris, adding water for decoction, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate, adding other auxiliary materials according to requirements, uniformly mixing, and finally grinding and sieving to obtain medicinal powder.
The obtained medicinal powder is filled into capsule, and made into capsule, which is taken with warm boiled water.
Example 3
A composition for gout and reducing uric acid, which comprises the following raw materials in percentage by weight:
30g of ginseng, 30g of orange peel, 25g of resistant dextrin, 40g of honeysuckle extract, 30g of green tea extract, 40g of Jiuhua rhizoma polygonati, 35g of sodium citrate, 40g of liquorice, 35g of potassium citrate, 55g of black wolfberry, 35g of ferric citrate, 35g of chrysanthemum, 35g of manganese citrate and 50g of cordyceps militaris.
The embodiment also provides application of the composition for treating gout and reducing uric acid, and the composition is used for preparing oral medicaments.
The embodiment also provides a preparation method of the medicament, which comprises the following steps: weighing the raw materials according to a certain proportion, cleaning and drying the washable medicinal materials in the raw materials, crushing and pulverizing ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum and cordyceps militaris, adding water for decoction, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate, adding other auxiliary materials according to requirements, uniformly mixing, and finally grinding and sieving to obtain medicinal powder.
The obtained medicinal powder is taken as granule with warm boiled water; or encapsulating to obtain capsule, and administering with warm water.
The raw materials adopted in the embodiments of the invention respectively accord with the corresponding national standards and regulations.
Clinical trials of the medicament prepared by the embodiments of the invention prove that the composition has obvious effect and can be used for preparing a specific medicament for pertinently treating gout and hyperuricemia.
The composition for gout and uric acid reduction and the application and the preparation method thereof provided by the invention are prepared by combining natural Chinese herbal medicines and raw materials with homology of medicine and food, are prepared based on ancient manual processing, are combined with modern similar biological and pharmaceutical technologies, are prepared by purifying, concentrating, mixing and pulverizing, and are new after being promoted, so that the special-effect medicament for reducing the magic volt wind poison which can be orally taken can be finally produced. The medicine is also named as Jiuzhen Zhengfeng powder.
The composition also has the characteristics of reasonable formula, small dosage, obvious effect, small toxic and side effect, quick response, difficult relapse and the like, and has the advantages of simple and easily obtained components, convenient processing, low price, high quality, economy, practicability and the like.
While the present invention has been described in detail with reference to the preferred embodiments, it should be understood that the above description should not be taken as limiting the invention. Various modifications and alterations to this invention will become apparent to those skilled in the art upon reading the foregoing description. Accordingly, the scope of the invention should be determined from the following claims.
Claims (8)
1. A composition for gout and reducing uric acid is characterized in that the raw materials of the composition comprise: ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum, cordyceps militaris, honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate.
2. The composition for gout and uric acid reduction as claimed in claim 1, wherein the raw materials of the composition comprise polygonatum sibiricum and lycium ruthenicum.
3. The composition for gout and uric acid reduction according to claim 2, wherein the composition comprises the following raw materials in parts by weight: 20-30 parts of ginseng, 20-30 parts of orange peel, 15-25 parts of resistant dextrin, 30-40 parts of honeysuckle extract, 20-30 parts of green tea extract, 30-40 parts of Jiuhua sealwort, 25-35 parts of sodium citrate, 30-40 parts of liquorice, 25-35 parts of potassium citrate, 45-55 parts of black wolfberry, 25-35 parts of ferric citrate, 25-35 parts of chrysanthemum, 25-35 parts of manganese citrate and 40-50 parts of cordyceps militaris.
4. The composition for gout and uric acid reduction as claimed in claim 3, wherein the raw materials of the composition comprise, by weight: 25g of ginseng, 25g of orange peel, 20g of resistant dextrin, 35g of honeysuckle extract, 25g of green tea extract, 35g of Jiuhua sealwort, 30g of sodium citrate, 35g of liquorice, 30g of potassium citrate, 50g of black wolfberry, 30g of ferric citrate, 30g of chrysanthemum, 30g of manganese citrate and 45g of cordyceps militaris.
5. Use of the composition for gout and uric acid reduction according to any one of claims 1 to 4, wherein the composition is used for preparing a medicament for internal administration.
6. A method of preparing the medicament of claim 5, wherein the method comprises: weighing the raw materials in proportion, cleaning and drying the washable medicinal materials in the raw materials, grinding and crushing the medicinal materials, adding water for decocting, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding the rest raw materials, uniformly mixing, and finally processing into an oral medicament.
7. The method for preparing the medicament as claimed in claim 6, wherein the method comprises the steps of crushing and pulverizing ginseng, orange peel, rhizoma polygonati, liquorice, medlar, chrysanthemum and cordyceps militaris, adding water for decoction, filtering to obtain liquid medicine, further concentrating to obtain ointment, drying, adding honeysuckle extract, green tea extract, resistant dextrin, sodium citrate, potassium citrate, manganese citrate and ferric citrate, adding other auxiliary materials according to requirements, mixing uniformly, grinding and sieving to obtain medicinal powder.
8. The method for preparing the medicament of claim 7, wherein the powder is taken as granules with warm boiled water; or encapsulating to obtain capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210116349.6A CN114404517A (en) | 2022-02-07 | 2022-02-07 | Composition for gout and reducing uric acid and application and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210116349.6A CN114404517A (en) | 2022-02-07 | 2022-02-07 | Composition for gout and reducing uric acid and application and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114404517A true CN114404517A (en) | 2022-04-29 |
Family
ID=81279942
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210116349.6A Pending CN114404517A (en) | 2022-02-07 | 2022-02-07 | Composition for gout and reducing uric acid and application and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114404517A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172770A (en) * | 2018-11-13 | 2019-01-11 | 张洪搏 | Facilitate the herbal composite and preparation method thereof of uric acid adjusting |
| CN110559389A (en) * | 2019-09-23 | 2019-12-13 | 阳元贵 | traditional Chinese medicine wine for treating hyperuricemia, gout and rheumatism and preparation method thereof |
-
2022
- 2022-02-07 CN CN202210116349.6A patent/CN114404517A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109172770A (en) * | 2018-11-13 | 2019-01-11 | 张洪搏 | Facilitate the herbal composite and preparation method thereof of uric acid adjusting |
| CN110559389A (en) * | 2019-09-23 | 2019-12-13 | 阳元贵 | traditional Chinese medicine wine for treating hyperuricemia, gout and rheumatism and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104940606A (en) | Deer-horn gelatin health product for conditioning eight types of abnormal body constitution | |
| CN112121144B (en) | Roxburgh rose composition and preparation method and application thereof | |
| CN103493941A (en) | Weight-reducing and health-protecting tea and preparation method thereof | |
| CN101612315A (en) | A kind of compound Chinese medicinal preparation that is used to adjust function of human body | |
| CN105852084A (en) | Functional food composition capable of reducing weight and reducing blood lipid and preparation method of functional food composition | |
| CN103555530A (en) | Lily healthcare medicinal liquor | |
| KR20160119999A (en) | Gongjindan based on dongibogam and method of manufacturing the same | |
| CN101011562B (en) | Novel formulation of shenqiwendan decoction and production method thereof | |
| CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
| CN103977206B (en) | Improve Chinese medicine preparation and the production method thereof of gastrointestinal disturbances systemic-function | |
| CN107114781B (en) | Health food for protecting liver and preparation method thereof | |
| CN102604802B (en) | Preparation method of originally ecological bamboo-germanium nutritional wine | |
| CN112618691A (en) | Traditional Chinese medicine composition with qi and blood tonifying effect and preparation method and application thereof | |
| KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
| CN111587942A (en) | Instant tea powder of sixteen kinds of natural Chinese herbal medicine and its prepn and use | |
| CN102349950B (en) | Food, health product or pharmaceutical composition as well as preparation method and application thereof | |
| CN103734767A (en) | Health-care food | |
| CN106860814B (en) | Health food composition for improving female frequent micturition and urinary incontinence and preparation method and application thereof | |
| KR101783549B1 (en) | Health supplement food containing dha for recovering fatigue, and method of manufacturing the same | |
| CN107823293A (en) | Treat Yao nationality medicine external pulvis of canker sore and preparation method thereof | |
| CN103690811A (en) | Traditional Chinese medicine oral liquid for lowering blood pressure and preventing dizziness and preparation method thereof | |
| CN102613648A (en) | Preparation method of original ecological bamboo germanium nutrient solution | |
| CN108813500B (en) | Health-preserving honey paste with effects of tonifying middle-jiao and Qi, nourishing blood and soothing nerves and regulating human body functions | |
| CN114404517A (en) | Composition for gout and reducing uric acid and application and preparation method thereof | |
| CN111543526A (en) | Inonotus obliquus and cordyceps sinensis health-care tea capable of tonifying liver, tonifying kidney and dispelling wind |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220429 |
|
| RJ01 | Rejection of invention patent application after publication |